Novartis
NVS
$94.36
Share price
1.93%
Change (1 day)
-3.73%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Revenue for Novartis (NVS)
Revenue in 2023 (TTM): $51.01 B
According to Novartis's latest financial reports the company's current revenue (TTM) is $51.01 B. In 2022 the company made a revenue of $49.76 B a decrease over the years 2021 revenue that were of $52.87 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Novartis from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $51.01 B | 2.5% |
| 2022 | $49.76 B | -5.88% |
| 2021 | $52.87 B | 5.97% |
| 2020 | $49.89 B | 2.51% |
| 2019 | $48.67 B | 1.69% |
| 2018 | $47.86 B | -4.53% |
| 2017 | $50.13 B | 1.41% |
| 2016 | $49.43 B | -1.89% |
| 2015 | $50.38 B | -6.05% |
| 2014 | $53.63 B | -3.8% |
| 2013 | $55.75 B | -3.14% |
| 2012 | $57.56 B | -3.06% |
| 2011 | $59.37 B | 15.15% |
| 2010 | $51.56 B | 14.32% |
| 2009 | $45.10 B | 5.92% |
| 2008 | $42.58 B | 9.86% |
| 2007 | $38.76 B | 10.75% |
| 2006 | $35.00 B | 7.85% |
| 2005 | $32.45 B | 14.89% |
| 2004 | $28.24 B | 13.61% |
| 2003 | $24.86 B | 6.62% |
| 2002 | $23.32 B | 19.8% |
| 2001 | $19.46 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 82.35% | 🇺🇸 USA |
 Pfizer PFE | $58.49 B | 14.67% | 🇺🇸 USA |
 Abbott Laboratories ABT | $40.10 B | -21.37% | 🇺🇸 USA |
 Sanofi SNY | $50.35 B | -1.28% | 🇫🇷 France |
 Merck MRK | $60.11 B | 17.84% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $45.00 B | -11.77% | 🇺🇸 USA |
 AstraZeneca AZN | $45.81 B | -10.20% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $37.84 B | -25.80% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $15.84 B | -68.94% | 🇮🇱 Israel |